Lazabemide (Ro 19-6327) is a selective, reversible inhibitor of monoamine oxidase B (MAO-B) (IC50=0.03 µM) but less active for MAO-A (IC50>100 µM). Lazabemide inhibits monoamine uptake at high concentrations, the IC50 values are 86 µM, 123 µM and >500 µM for noradrenalin, serotonin and dopamine uptake, respectively. Lazabemide can be used for the research of parkinson and alzheimer's disease[1].
Molecular Weight:
199.64
Purity:
99.95
CAS Number:
[103878-84-8]
Formula:
C8H10ClN3O
Target:
Monoamine Oxidase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
